Given that the loss of expression of ZNF677 in CRC correlates significantly with tumor invasion (T3/4 tumors) and advanced clinical stage of the malignancy, this protein might find useful clinical application not only as a prognostic indicator but also as a potential therapeutic target for guiding personalized medicine in CRC patients. The gene discussed is ZNF677; the disease is colorectal carcinoma.